Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment

Kelly L. Sullivan; Theresa A. Zesiewicz; Elan D. Louis; Martin Menkin; Peter B. Dunne; Robert A. Hauser

doi:10.1002/mds.20233

Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment

Kelly L. Sullivan
, Theresa A. Zesiewicz
, Elan D. Louis
, Martin Menkin
, Peter B. Dunne
, Robert A. Hauser

Biostatistics, Epidemiology & Environmental Health Sciences

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Disorder Society.

Original language	American English
Journal	Movement Disorder
Volume	19
DOIs	https://doi.org/10.1002/mds.20233
State	Published - Dec 19 2004

Disciplines

Public Health

Keywords

Levetiracetam treatment
Meige's Sydrome
Patient

Access to Document

10.1002/mds.20233License: Unspecified

Cite this

@article{7f0bb245ca2b47268a76ac964b439c4e,

title = "Substantial Improvement in a Meige{\textquoteright}s Syndrome Patient with Levetiracetam Treatment",

abstract = " We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. {\textcopyright} 2004 Movement Disorder Society.",

keywords = "Levetiracetam treatment, Meige's Sydrome, Patient",

author = "Sullivan, \{Kelly L.\} and Zesiewicz, \{Theresa A.\} and Louis, \{Elan D.\} and Martin Menkin and Dunne, \{Peter B.\} and Hauser, \{Robert A.\}",

note = "Enter your email address below. If your address has been previously registered, you will receive an email with instructions on how to reset your password. If you don't receive an email, you should register as a new user",

year = "2004",

month = dec,

day = "19",

doi = "10.1002/mds.20233",

language = "American English",

volume = "19",

journal = "Movement Disorder",

}

TY - JOUR

T1 - Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment

AU - Sullivan, Kelly L.

AU - Zesiewicz, Theresa A.

AU - Louis, Elan D.

AU - Menkin, Martin

AU - Dunne, Peter B.

AU - Hauser, Robert A.

N1 - Enter your email address below. If your address has been previously registered, you will receive an email with instructions on how to reset your password. If you don't receive an email, you should register as a new user

PY - 2004/12/19

Y1 - 2004/12/19

N2 - We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Disorder Society.

AB - We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Disorder Society.

KW - Levetiracetam treatment

KW - Meige's Sydrome

KW - Patient

UR - https://doi.org/10.1002/mds.20233

U2 - 10.1002/mds.20233

DO - 10.1002/mds.20233

M3 - Article

VL - 19

JO - Movement Disorder

JF - Movement Disorder

ER -

Substantial Improvement in a Meige’s Syndrome Patient with Levetiracetam Treatment

Abstract

Disciplines

Keywords

Access to Document

Other files and links

Fingerprint

Cite this